Billionaire Loeb Sold Shares in AI Leaders, Boosts AI Stock
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesIn quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
Archer Aviation is venturing into urban air mobility with electric VTOL aircraft. This piece analyzes the case for bu...
AI chip demand is reshaping tech markets, and Taiwan Semiconductor Manufacturing sits at the center. This article exp...
Turning 50 unlocks a powerful boost for retirement savings: catch-up contributions. This guide shows you exactly how ...
Green Court Capital Management just trimmed its New Oriental Education stake, a move that raises questions about EDU'...
Redwire stock swung sharply during today’s session, leaving investors with questions about its business model and gro...
Investors are abuzz about SpaceX's IPO, but two alarming statistics could quietly derail returns. This guide breaks d...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
During a broad AI stock drawdown, Cathie Wood doubling down on CoreWeave signals a high-conviction bet. This article ...
Palantir trades sales. Here's a clear-eyed view of why the market pays up for this AI-driven data platform, plus acti...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
If you’re seeking a single, enduring reason to own Lilly stock, this article lays it out. You’ll learn how a durable ...